Conducting a supportive oncology clinical trial during the COVID-19 pandemic: challenges and strategies
Jie Deng, John N Lukens, Joy C Cohn, Erin McMenamin, Barbara Murphy, Bryan A Spinelli, Niya Murphy, Alicia K Steinmetz, Megan A Landriau, Alexander Lin, Jie Deng, John N Lukens, Joy C Cohn, Erin McMenamin, Barbara Murphy, Bryan A Spinelli, Niya Murphy, Alicia K Steinmetz, Megan A Landriau, Alexander Lin
Abstract
The coronavirus disease 2019 (COVID-19) pandemic resulted in severe interruptions to clinical research worldwide. This global public health crisis required investigators and researchers to rapidly develop and implement new strategies and solutions to mitigate its negative impact on the progress of clinical trials. In this paper, we describe the challenges, strategies, and lessons learned regarding the continuation of a supportive oncology clinical trial during the pandemic. We hope to provide insight into the implementation of clinical trials during a public health emergency to be better prepared for future instances.Trial registration: ClinicalTrials.gov, a service of the US National Institute of Health (NCT03030859). Registered on 22 January 2017.
Keywords: COVID-19; Clinical trials; Fibrosis; Head and neck cancer; Lymphedema; Pandemic; Participant safety; Telehealth; Trial operation; Virtual visits.
Conflict of interest statement
The authors declare that they have no competing interests.
© 2022. The Author(s).
Figures
References
- Impact of COVID-19 on people’s livelihoods, their health and our food systems - joint statement by ILO, FAO, IFAD and WHO. Available from: . Accessed 10 Aug 2020.
- Sathian B, Asim M, Banerjee I, Pizarro AB, Roy B, van Teijlingen ER, do Nascimento I, Alhamad HK. Impact of COVID-19 on clinical trials and clinical research: a systematic review. Nepal J Epidemiol. 2020;10(3):878–887. doi: 10.3126/nje.v10i3.31622.
- FDA Guidance on conduct of clinical trials of medical products during the COVID-19 public health emergency - guidance for industry, investigators, and institutional review boards (March 2020). U.S. Food & Drug Administration. Available from: . Accessed 10 Aug 2021.
- Nishiwaki S, Ando Y. COVID-19 pandemic and trends in clinical trials: a multi-region and global perspective. Front Med (Lausanne) 2021;8:812370. doi: 10.3389/fmed.2021.812370.
- . Self-care for head and neck cancer survivors with lymphedema and fibrosis. U.S. NIH; 2017. Available from: . Accessed 10 Aug 2021.
- Deng J, Dietrich MS, Murphy B. Self-care for head and neck cancer survivors with lymphedema and fibrosis: study protocol for a randomized controlled trial. Trials. 2019;20(1):775. doi: 10.1186/s13063-019-3819-0.
- Penn Medicine updated clinical research guidance in relation to COVID-19 (corona virus) (March 13, 2020). Available from: . Accessed 12 Aug 2021.
- City issues stay at home order clarifying restrictions on business activity in Philadelphia (March 22, 2020). Available from: . Accessed 12 Aug 2021.
- Audisio K, Lia H, Robinson NB, Rahouma M, Soletti G, Jr, Cancelli G, Perezgrovas Olaria R, Chadow D, Tam DY, Vervoort D, Farkouh ME, Bhatt DL, Fremes SE, Gaudino M. Impact of the COVID-19 pandemic on non-COVID-19 clinical trials. J Cardiovasc Dev Dis. 2022;9(1):19. doi: 10.3390/jcdd9010019.
- Deng J, Lukens JN, Swisher-McClure S, Cohn JC, Spinelli B, Quinn RJ, Chittams J, McMenamin E, Lin A. Photobiomodulation therapy in head and neck cancer-related lymphedema: a pilot feasibility study. Integr Cancer Ther. 2021;20:15347354211037938. doi: 10.1177/15347354211037938.
Source: PubMed